HPLC, UHPLC

  • Optimised HPLC Analysis of Monoclonal Antibodies (mAbs)
  • Figure 1.
  • Figure 2.

Optimised HPLC Analysis of Monoclonal Antibodies (mAbs)

Nov 23 2016 Read 1376 Times

Monoclonal antibodies (mAbs) are complex macromolecules that are developed as biotherapeutics themselves, or as targeting vehicles for delivery of toxic payloads (antibody drug conjugates). As complex macromolecules, they require multipronged approaches to analysis and characterisation, whether under development or to support production QC. Analysis of the intact mAb, can provide first level assessment of size, post-translational modifications, and heterogeneity. Such questions can be readily addressed by reversed-phase chromatography (RPC) coupled to the analytical power of mass spectrometry. RPC of proteins, particularly as large as IgG, requires the use of a large pore chromatographic matrix, a hydrophobic stationary phase, and appropriate chromatographic conditions – mobile phase and temperature. The typical phase for RP protein chromatography is a short alkyl chain, which provides adequate retention. By way of RP mobile phase conditions, however, mAbs generally require an elevated temperature for efficient chromatography. It has also been reported that the chromatography can be further enhanced by the inclusion of a protic solvent as a component of the organic modifier (the strong solvent). In addition to optimising the chromatographic conditions, new developments in particle technology have resulted in gains in chromatographic performance. These technology developments have been applied to both traditional porous particles and new core-shell (or superficially porous) particle design. For porous particles, the advancements have come in smaller particle size and chemical stability. For core-shell particles, the technological advancement is in the particle architecture itself - limiting the chromatographic separation process to the thin outer porous layer. Additionally, the synthetic route to the core-shell particle may yield a narrower particle size distribution, which in turn can affect chromatographic packing such that improved column efficiency is attained.

The figures compare the chromatographic results of two such modern columns designed for intact protein analysis. In Figure 1, the sample is the mAb adalimumab (aka Humira®), while for Figure 2, the sample is a mAb standard from MilliporeSigma (MSQC4). Both new columns were run on the same day with the same sample, on the same UHPLC instrument. A common method was used for both columns, at a temperature optimum of 75°C. It is clear that the core-shell column provides considerably narrower peak width (and thus better sensitivity), and as a result of the superior performance, also better resolves minor components of the sample. The enhanced performance of the core-shell column will be best realised in combination with a modern UHPLC instrument of minimal system dispersion. Please click here for additional information.

Chromatographic Conditions:

column as indicated, 10 cm x 2.1 mm I.D.
mobile phase A 80:20, (water, 0.1% TFA):(acetonitrile, 0.1% TFA)
mobile phase B 50:50, (water, 0.1% TFA):(acetonitrile, 0.1% TFA)
flow rate 0.2 mL/min
gradient 45 to 57% B in 12 min
column temp 75°C
det UV, 215 nm
injection 0.3 µL Humira or 1.0 µL SigmaMAb
sample mAb diluted in 20 mM Tricine/KOH, pH 7, to 1 g/L
Read comments0

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.


Digital Edition

Chromatography Today - Buyers Guide 2019

December 2018

In This Edition Articles Fundamental Aspects - Improved Biomacromolecule Separations Using Superficially Porous Particles with a 1000 Å Pore Diameter - A Deep Characterisation of Monoclo...

View all digital editions

Events

SCM-9

Jan 30 2019 Amsterdam, Netherlands

World Congress on Chromatography

Jan 31 2019 Paris, France

MEDLAB MIDDLE EAST

Feb 04 2019 Dubai, UAE

China Lab 2019

Feb 26 2019 Guangzhou, China

Israchem

Mar 12 2019 Tel Aviv, Israel

View all events